Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedAug 21, 2026
DataAggregated Company Financials
Companies21
  • 7D-0.4%
  • 3M12.8%
  • 1Y-18.2%
  • YTD-6.7%

The Pharma industry is up 1.0% in the last week, with Swedencare up 2.8%. In contrast, the industry has lost 16% in the last 12 months. As for the next few years, earnings are expected to grow by 38% per annum.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 21 Aug 2026SEK 47.3bSEK 5.3b-SEK 703,713,144.0049.6x-67.2x8.9x
Sun, 19 Jul 2026SEK 47.0bSEK 5.3b-SEK 290,907,144.0069.5x-161.7x8.9x
Tue, 16 Jun 2026SEK 45.0bSEK 5.3b-SEK 1,275,205,144.0067.9x-35.3x8.5x
Thu, 14 May 2026SEK 42.6bSEK 5.3b-SEK 1,247,986,145.0063.4x-34.1x8.1x
Sat, 11 Apr 2026SEK 43.5bSEK 5.3b-SEK 1,376,536,671.0060.4x-31.6x8.3x
Mon, 09 Mar 2026SEK 41.3bSEK 5.3b-SEK 1,377,968,671.0054.6x-30x7.8x
Wed, 04 Feb 2026SEK 51.1bSEK 5.3b-SEK 1,000,645,157.0055.1x-51.1x9.6x
Fri, 02 Jan 2026SEK 49.9bSEK 5.3b-SEK 531,735,157.0072.3x-93.8x9.4x
Sun, 30 Nov 2025SEK 50.0bSEK 5.3b-SEK 523,264,021.0071.4x-95.6x9.4x
Tue, 28 Oct 2025SEK 50.9bSEK 5.1b-SEK 433,356,865.0076.6x-117.5x9.9x
Thu, 25 Sep 2025SEK 54.5bSEK 5.1b-SEK 405,183,865.0069.6x-134.5x10.7x
Sat, 23 Aug 2025SEK 56.6bSEK 5.1b-SEK 327,043,676.0079.2x-172.9x11.1x
Mon, 21 Jul 2025SEK 57.5bSEK 5.0b-SEK 347,188,364.0069.2x-165.7x11.4x
Wed, 18 Jun 2025SEK 49.7bSEK 4.8b-SEK 574,344,160.2866.5x-86.6x10.3x
Fri, 16 May 2025SEK 46.6bSEK 4.8b-SEK 603,406,964.9063.9x-77.2x9.6x
Sun, 13 Apr 2025SEK 45.9bSEK 4.7b-SEK 807,022,812.2265.7x-56.9x9.7x
Tue, 11 Mar 2025SEK 49.4bSEK 4.7b-SEK 809,467,746.1673x-61x10.5x
Thu, 06 Feb 2025SEK 51.9bSEK 4.4b-SEK 809,643,207.74133.9x-64.1x11.7x
Sat, 04 Jan 2025SEK 51.5bSEK 4.4b-SEK 615,648,418.17130.2x-83.6x11.6x
Mon, 02 Dec 2024SEK 51.1bSEK 4.4b-SEK 617,911,730.25126.9x-82.7x11.5x
Wed, 30 Oct 2024SEK 52.6bSEK 4.3b-SEK 686,768,690.13142.8x-76.6x12.1x
Fri, 27 Sep 2024SEK 65.0bSEK 5.9b-SEK 1,169,874,226.06170.6x-55.6x11x
Sun, 25 Aug 2024SEK 68.9bSEK 5.9b-SEK 939,207,156.0688.7x-73.4x11.7x
Tue, 23 Jul 2024SEK 68.1bSEK 5.5b-SEK 997,535,971.21115.3x-68.3x12.3x
Thu, 20 Jun 2024SEK 63.0bSEK 6.4b-SEK 862,342,259.7571.7x-73.1x9.9x
Sat, 18 May 2024SEK 53.4bSEK 6.4b-SEK 767,607,267.7571.8x-69.6x8.4x
Mon, 15 Apr 2024SEK 51.3bSEK 6.2b-SEK 1,040,626,304.1977.9x-49.3x8.2x
Wed, 13 Mar 2024SEK 50.6bSEK 6.2b-SEK 1,038,034,723.1675.6x-48.8x8.1x
Fri, 09 Feb 2024SEK 52.8bSEK 6.0b-SEK 861,697,426.1267.4x-61.2x8.8x
Sun, 07 Jan 2024SEK 69.1bSEK 9.4b-SEK 1,184,310,332.0064.2x-58.3x7.3x
Tue, 05 Dec 2023SEK 62.7bSEK 9.5b-SEK 1,209,395,296.0057.3x-51.8x6.6x
Thu, 02 Nov 2023SEK 52.8bSEK 9.3b-SEK 1,115,144,896.0080x-47.3x5.7x
Sat, 30 Sep 2023SEK 51.1bSEK 9.2b-SEK 1,177,239,896.00122.3x-43.4x5.6x
Mon, 28 Aug 2023SEK 50.3bSEK 9.2b-SEK 1,128,230,548.00140.6x-44.6x5.5x
Price to Earnings Ratio

-44.6x


Total Market Cap: SEK 50.3bTotal Earnings: -SEK 1,128,230,548.00Total Revenue: SEK 9.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -75.7x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swedish Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 9.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 17% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-0.68%
Healthcare1.93%
Pharma-0.44%
Pharma-0.44%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SECARE SwedencareSEK 22.002.8%
+SEK 95.9m		-43.1%PE43.9x
CINPHA Cinclus Pharma HoldingSEK 13.1010.8%
+SEK 59.6m		-17.2%PS17.3x
KLAR Klaria Pharma Holding AB (publ.)SEK 1.0413.3%
+SEK 30.0m		116.6%PS2563.1x
DICOT Dicot PharmaSEK 0.213.2%
+SEK 22.2m		-78.0%PB12.4x
MOB Moberg PharmaSEK 11.323.5%
+SEK 17.9m		42.4%PS31.9x

Latest News

ERMA
SEK 0.60
Enorama Pharma
7D
54.1%
1Y
-76.8%
CINPHA
SEK 13.10
Cinclus Pharma Holding
7D
10.8%
1Y
-17.2%
MOB
SEK 11.32
Moberg Pharma
7D
3.5%
1Y
42.4%
Narrative Update • Aug 14

MOB: Expanded Licensing And Upcoming Launches Will Drive Future Upside Potential

Analysts have raised their price target for Moberg Pharma from SEK 14 to SEK 16, citing updated assumptions for fair value, discount rate, revenue growth, profit margin and future P/E as the key drivers of the change. What's in the News for Moberg Pharma The first European countries have approved the rebranding of MOB-015 (Terclara) to Karo Healthcare's brand, which creates a clearer timetable for launch preparations and marketing activities in those markets.
KLAR
SEK 1.04
Klaria Pharma Holding AB (publ.)
7D
13.3%
1Y
116.6%
ENZY
SEK 1.93
Enzymatica
7D
-6.1%
1Y
-18.1%
SECARE
SEK 22.00
Swedencare
7D
2.8%
1Y
-43.1%
CESSA
DKK 9.10
Cessatech
7D
-8.8%
1Y
-22.6%
PILA
SEK 1.70
Pila Pharma
7D
23.2%
1Y
-24.1%
DICOT
SEK 0.21
Dicot Pharma
7D
3.2%
1Y
-78.0%
ORX
SEK 14.02
Orexo
7D
-10.5%
1Y
-33.9%
CAMX
SEK 630.00
Camurus
7D
-0.7%
1Y
-8.9%
NEWBRY
SEK 2.44
Newbury Pharmaceuticals
7D
-15.3%
1Y
-6.2%
FLERIE
SEK 19.75
Flerie
7D
-2.7%
1Y
-46.7%
IRLAB A
SEK 1.72
IRLAB Therapeutics
7D
5.9%
1Y
-43.3%
ALZCUR
SEK 6.64
AlzeCure Pharma
7D
-1.2%
1Y
69.8%
IBT B
SEK 65.70
Infant Bacterial Therapeutics
7D
-2.7%
1Y
23.5%
Analysis Article • Apr 20

We're Hopeful That Infant Bacterial Therapeutics (STO:IBT B) Will Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...